Remember meForgot password?
    Log in with Twitter
| Press Release

Zilis Applauds Passage of Hemp-Friendly 2018 Farm Bill

Will Open Door for Innovation in Hemp, CBD Oil, and Agricultural Entrepreneurship

ARGYLE, TX / ACCESSWIRE / December 12, 2018 / Zilis LLC, a leader in the hemp-derived CBD oil business through its UltraCell® products, applauds the bi-partisan passage of the 2018 Farm Bill, which passed this House of Representatives this afternoon - after passing the Senate earlier this week - and is expected to be signed into law in the next few days. This bill contains hemp-friendly language that will eventually allow for the hemp plant to be grown throughout the country, and for hemp products containing cannabidiol ("CBD") to be sold without restriction anywhere in the US.

Most importantly, this law will mean that hemp and hemp-derived products such as CBD oil will be removed from the "Schedule 1" of the Controlled Substances Act, and will be treated like other commodity crops, such as corn or soybeans.

Zilis Founder and CEO Steven Thompson commented: "We are beyond thrilled to see that the House and Senate could come together in such a bi-partisan fashion to get this Farm Bill to the finish line. The hemp provisions, now law, create more opportunities for people across America to access the CBD oil found in the hemp plant, and pave the way for more innovation and entrepreneurship for the agriculture industry in the US."

For centuries, the hemp plant has been used for its medicinal benefits. CBD, or cannabidiol, is a compound found in both hemp and its cousin, marijuana. A key difference with hemp-derived CBD is that hemp products, like UltraCell, contain only trace amounts of THC, the psychoactive component found in the Schedule 1 marijuana plant.

Zilis, which launched in 2015, created UltraCell as an ingestible CBD oil in November 2017, and followed up with UltraCell Topical in September. Two hallmarks of the UltraCell brand since its launch are absorption and bioavailability: UltraCell full spectrum hemp oil has shown absorption at 94 percent, and the bioavailability, made possible thanks to the water solubility of the UltraCell technology, is designed to be both fast acting and long lasting.

About Zilis LLC

Zilis®, is the creator of UltraCell®, a CBD oil product derived from hemp. With independent direct sales ambassadors throughout the country, Zilis has been at the forefront of the movement to harness the power of hemp, and specifically its CBD oil, which is used by tens of thousands throughout the world as a dietary supplement. Based in Argyle, Texas, a suburb of Dallas-Fort Worth, Zilis is privately held. Zilis and its ambassadors are committed to giving back through the "Pay It Forward" nutrition program. Since 2015, the company has donated tens of millions of days' worth of vitamin supplements to young children and pregnant women in all 50 states and the developing world. Visit for more information.

Product Disclaimer

Zilis products have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease or medical conditions. The information on the Zilis website, marketing materials, product labels or packaging is not intended as medical advice and should not substitute advice from a healthcare professional. Please consult with your physician or other healthcare provider if you have health-related questions before using any of our products or relying on any information you obtain from the Zilis website. You should discuss any medications or nutritional supplements you are using with a healthcare provider before using any new medications or supplements. Always review the labels, warnings, and directions included with your product before using or consuming the product and do not rely solely on the information shown on the Zilis website.

For More Information, Contact:

Dave Van de Walle
(940) 535-7200, ext. 819


View source version on

Latest News
Top News